Human Arm protein lost in epithelial cancers, on chromosome X 1 (ALEX1) gene is transcriptionally regulated by CREB and Wnt/beta-catenin signaling.
The aberrant activation of Wnt signaling is a key process in colorectal tumorigenesis. Canonical Wnt signaling controls transcription of target genes via beta-catenin and T-cell factor/lymphoid enhancer factor family transcription factor complex. Arm protein lost in epithelial cancers, on chromosome X 1 (ALEX1) is a novel member of the Armadillo family which has two Armadillo repeats as opposed to more than six repeats in the classical Armadillo family members. Here we examine cis-regulatory elements and trans-acting factors involved in the transcriptional regulation of the ALEX1 gene. Site-directed mutations of a cyclic AMP response element (CRE) and an E-box impaired the basal activity of human ALEX1 promoter in colorectal and pancreatic cancer cell lines. Moreover, overexpression of CRE-binding protein (CREB) increased the ALEX1 promoter activity in these cell lines, whereas knockdown of CREB expression decreased the expression level of ALEX1 mRNA. Interestingly, luciferase reporter analysis and quantitative real-time RT-PCR demonstrated that the ALEX1 promoter was up-regulated in a CRE-dependent manner by continuous activation of Wnt/beta-catenin signaling induced by a glycogen synthase kinase-3 inhibitor and overexpression of beta-catenin. These results indicate that the CRE and E-box sites are essential cis-regulatory elements for ALEX1 promoter activity, and ALEX1 expression is regulated by CREB and Wntk/beta-catenin signaling.
Iseki
Hiroyoshi
H
Department of Digestive Surgery, Saitama Medical University, Saitama, Japan.
Takeda
Akihiko
A
Andoh
Toshiwo
T
Takahashi
Norio
N
Kurochkin
Igor V
IV
Yarmishyn
Aliaksandr
A
Shimada
Hideaki
H
Okazaki
Yasushi
Y
Koyama
Isamu
I
D051186:Armadillo Domain Proteins / Q000235:genetics*; D017362:Cyclic AMP Response Element-Binding Protein / Q000502:physiology*; D005786:Gene Expression Regulation; D045325:HCT116 Cells; D006801:Humans; D015513:Oncogene Proteins / Q000235:genetics*; D011401:Promoter Regions, Genetic; D015398:Signal Transduction; D014158:Transcription, Genetic; D051153:Wnt Proteins / Q000502:physiology*; D051176:beta Catenin / Q000502:physiology*
C422103:ARMCX1 protein, human; D051186:Armadillo Domain Proteins; C115163:CREB1 protein, human; D017362:Cyclic AMP Response Element-Binding Protein; D015513:Oncogene Proteins; D051153:Wnt Proteins; D051176:beta Catenin
Dev Dyn. 2005 May;233(1):188-93
15759267
Nat Rev Mol Cell Biol. 2001 Aug;2(8):599-609
11483993
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3324-9
17360646
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7
10318916
Cell. 2002 Nov 27;111(5):673-85
12464179
Genes Dev. 1995 Apr 15;9(8):995-1008
7774816
Nature. 1999 Apr 1;398(6726):422-6
10201372
Annu Rev Biochem. 1999;68:821-61
10872467
Genes Dev. 2000 Mar 1;14(5):585-95
10716946
Cell. 2006 May 5;125(3):593-605
16678101
Nature. 2005 Apr 14;434(7035):843-50
15829953
Science. 2005 May 20;308(5725):1181-4
15905404
Biochem Biophys Res Commun. 2001 Jan 12;280(1):340-7
11162520
Clin Cancer Res. 2004 Feb 15;10(4):1401-8
14977843
J Cell Sci. 2007 Oct 1;120(Pt 19):3337-44
17881495
J Biol Chem. 2008 Jan 11;283(2):809-15
17962194
Oncogene. 2004 Apr 29;23(20):3689-99
15116100
J Clin Oncol. 2000 May;18(9):1967-79
10784639
Clin Cancer Res. 2007 Jul 15;13(14):4042-5
17634527
Cancer Res. 2003 Jun 15;63(12):3145-53
12810642
Science. 1998 Sep 4;281(5382):1509-12
9727977